Aquestive Therapeutics Inc
Research Aquestive Therapeutics Inc (AQST) on Bullrun: market cap USD 521.87M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerAQST
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Market capUSD 521.87M
- Financial periodFY2025
- RevenueUSD 44.55M
- Revenue growth-22.6%
- Net income-USD 83.78M
- Free cash flow-USD 52.99M
- Gross margin58.3%
Valuation Snapshot
latest market cap is USD 521.87M.
About Aquestive Therapeutics Inc
Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. It offers Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; EMYLIF, an oral film formulation of riluzole; ONDIF, an oral soluble film formulation of ondansetron;
Frequently asked questions
What is Aquestive Therapeutics Inc's market cap?
Aquestive Therapeutics Inc's market capitalization is USD 521.87M.
What does Aquestive Therapeutics Inc do?
Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. It offers Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures;